dc.contributor.author |
Yi, JS |
|
dc.contributor.author |
Guidon, A |
|
dc.contributor.author |
Sparks, S |
|
dc.contributor.author |
Osborne, R |
|
dc.contributor.author |
Juel, VC |
|
dc.contributor.author |
Massey, JM |
|
dc.contributor.author |
Sanders, DB |
|
dc.contributor.author |
Weinhold, KJ |
|
dc.contributor.author |
Guptill, JT |
|
dc.coverage.spatial |
England |
|
dc.date.accessioned |
2015-06-16T19:33:36Z |
|
dc.date.issued |
2014-08 |
|
dc.identifier |
http://www.ncbi.nlm.nih.gov/pubmed/24378287 |
|
dc.identifier |
S0896-8411(13)00152-2 |
|
dc.identifier.uri |
https://hdl.handle.net/10161/10224 |
|
dc.description.abstract |
Muscle specific tyrosine kinase myasthenia gravis (MuSK MG) is a form of autoimmune
MG that predominantly affects women and has unique clinical features, including prominent
bulbar weakness, muscle atrophy, and excellent response to therapeutic plasma exchange.
Patients with MuSK MG have predominantly IgG4 autoantibodies directed against MuSK
on the postsynaptic muscle membrane. Lymphocyte functionality has not been reported
in this condition. The goal of this study was to characterize T cell responses in
patients with MuSK MG. Intracellular production of IFN-gamma, TNF-alpha, IL-2, IL-17,
and IL-21 by CD4+ and CD8+ T cells was measured by polychromatic flow cytometry in
peripheral blood samples from 11 Musk MG patients and 10 healthy controls. Only one
MuSK MG patient was not receiving immunosuppressive therapy. Regulatory T cells (Treg)
were also included in our analysis to determine if changes in T cell function were
due to altered Treg frequencies. CD8+ T cells from MuSK MG patients had higher frequencies
of polyfunctional responses than controls, and CD4+ T cells had higher IL-2, TNF-alpha,
and IL-17. MuSK MG patients had a higher percentage of CD4+ T cells producing combinations
of IFN-gamma/IL-2/TNF-gamma, TNF-alpha/IL-2, and IFN-gamma/TNF-alpha. Interestingly,
Treg numbers and CD39 expression were not different from control values. MuSK MG patients
had increased frequencies of Th1 and Th17 cytokines and were primed for polyfunctional
proinflammatory responses that cannot be explained by a defect in CD39 expression
or Treg number.
|
|
dc.language |
eng |
|
dc.publisher |
Elsevier BV |
|
dc.relation.ispartof |
J Autoimmun |
|
dc.relation.isversionof |
10.1016/j.jaut.2013.12.005 |
|
dc.subject |
Autoimmunity |
|
dc.subject |
Human |
|
dc.subject |
MuSK protein |
|
dc.subject |
Myasthenia gravis |
|
dc.subject |
Regulatory |
|
dc.subject |
T-lymphocytes |
|
dc.subject |
Adult |
|
dc.subject |
Aged |
|
dc.subject |
CD8-Positive T-Lymphocytes |
|
dc.subject |
Cell Separation |
|
dc.subject |
Cytokines |
|
dc.subject |
Female |
|
dc.subject |
Flow Cytometry |
|
dc.subject |
Humans |
|
dc.subject |
Immunoglobulin G |
|
dc.subject |
Immunophenotyping |
|
dc.subject |
Middle Aged |
|
dc.subject |
Myasthenia Gravis |
|
dc.subject |
Receptor Protein-Tyrosine Kinases |
|
dc.subject |
Receptors, Cholinergic |
|
dc.subject |
Sex Factors |
|
dc.subject |
Th1 Cells |
|
dc.subject |
Th17 Cells |
|
dc.subject |
Young Adult |
|
dc.title |
Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis. |
|
dc.type |
Journal article |
|
duke.contributor.id |
Yi, JS|0549750 |
|
duke.contributor.id |
Juel, VC|0169399 |
|
duke.contributor.id |
Massey, JM|0114600 |
|
duke.contributor.id |
Sanders, DB|0111892 |
|
duke.contributor.id |
Guptill, JT|0400442 |
|
pubs.author-url |
http://www.ncbi.nlm.nih.gov/pubmed/24378287 |
|
pubs.begin-page |
130 |
|
pubs.end-page |
138 |
|
pubs.organisational-group |
Basic Science Departments |
|
pubs.organisational-group |
Clinical Science Departments |
|
pubs.organisational-group |
Duke |
|
pubs.organisational-group |
Duke Cancer Institute |
|
pubs.organisational-group |
Duke Clinical Research Institute |
|
pubs.organisational-group |
Duke Human Vaccine Institute |
|
pubs.organisational-group |
Immunology |
|
pubs.organisational-group |
Institutes and Centers |
|
pubs.organisational-group |
Neurology |
|
pubs.organisational-group |
Neurology, Neuromuscular Disease |
|
pubs.organisational-group |
Pathology |
|
pubs.organisational-group |
School of Medicine |
|
pubs.organisational-group |
Surgery |
|
pubs.organisational-group |
Surgery, Surgical Sciences |
|
pubs.publication-status |
Published |
|
pubs.volume |
52 |
|
dc.identifier.eissn |
1095-9157 |
|
duke.contributor.orcid |
Yi, JS|0000-0001-7777-2437 |
|
duke.contributor.orcid |
Sanders, DB|0000-0003-2320-4965 |
|